MX9803422A - Apolipoproteina e2 y tratamiento de la enfermedad de alzheimer. - Google Patents

Apolipoproteina e2 y tratamiento de la enfermedad de alzheimer.

Info

Publication number
MX9803422A
MX9803422A MX9803422A MX9803422A MX9803422A MX 9803422 A MX9803422 A MX 9803422A MX 9803422 A MX9803422 A MX 9803422A MX 9803422 A MX9803422 A MX 9803422A MX 9803422 A MX9803422 A MX 9803422A
Authority
MX
Mexico
Prior art keywords
apolipoprotein
alzheimer
disease
treatment
apoe2
Prior art date
Application number
MX9803422A
Other languages
English (en)
Inventor
Vassilis I Zannis
Sergie B Aleshkov
Original Assignee
Kos Pharma Inc
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kos Pharma Inc, Univ Boston filed Critical Kos Pharma Inc
Publication of MX9803422A publication Critical patent/MX9803422A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Apolipoproteína E2 recombinante (apoE2), la cual se liga al péptido amiloide A-beta.
MX9803422A 1995-11-01 1998-04-30 Apolipoproteina e2 y tratamiento de la enfermedad de alzheimer. MX9803422A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55172295A 1995-11-01 1995-11-01

Publications (1)

Publication Number Publication Date
MX9803422A true MX9803422A (es) 1998-11-29

Family

ID=24202413

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9803422A MX9803422A (es) 1995-11-01 1998-04-30 Apolipoproteina e2 y tratamiento de la enfermedad de alzheimer.

Country Status (7)

Country Link
EP (1) EP0866799A4 (es)
JP (1) JP2000500332A (es)
AU (1) AU720446B2 (es)
BR (1) BR9611329A (es)
CA (1) CA2236274A1 (es)
MX (1) MX9803422A (es)
WO (1) WO1997016458A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1121429A2 (en) * 1998-10-16 2001-08-08 Introgene B.V. Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e
JP2002530122A (ja) * 1998-11-25 2002-09-17 サイオス インコーポレイテッド アミロイド関連疾患の予防及び治療
CN1315402A (zh) * 2000-03-28 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人淀粉类前体蛋白结合蛋白14和编码这种多肽的多核苷酸
CN1315439A (zh) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人淀粉类前体蛋白结合蛋白9和编码这种多肽的多核苷酸
US20070036761A1 (en) * 2003-09-26 2007-02-15 Bales Kelly R Lentiviral apoe2 gene therapy
EP1991252A2 (en) * 2006-02-21 2008-11-19 Oklahoma Medical Research Foundation Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor
WO2010020822A1 (en) * 2008-08-19 2010-02-25 University Of Patras Therapy for apolipoprotein-induced hypertriglyceridemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU587989B2 (en) * 1984-10-16 1989-09-07 Mitsubishi Chemical Corporation DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins
GB9414624D0 (en) * 1994-07-20 1994-09-07 Smithkline Beecham Plc Novel method

Also Published As

Publication number Publication date
WO1997016458A1 (en) 1997-05-09
EP0866799A1 (en) 1998-09-30
CA2236274A1 (en) 1997-05-09
AU7552696A (en) 1997-05-22
AU720446B2 (en) 2000-06-01
JP2000500332A (ja) 2000-01-18
BR9611329A (pt) 1999-12-28
EP0866799A4 (en) 2000-08-23

Similar Documents

Publication Publication Date Title
NZ305822A (en) Isolated presenilin genes and use in diagnosing Alzheimer's Disease
FI974432A (fi) Grampositiivisten bakteerien käyttö rekombinanttiproteiinien ilmentämiseksi
DE69831971D1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
HUP9900768A3 (en) Insecticidal protein toxins from photorhabdus
HK1014158A1 (en) Anti-fungal methods and materials
AU6916296A (en) Recombinant anti-cd4 antibodies for human therapy
EP0785276A4 (en) MODIFICATION OF A PEPTIDE AND A PROTEIN
AU4048295A (en) Peptide medicaments for the treatment of disease
AU3321595A (en) Recombinant production of biologically active peptides and proteins
ZA955740B (en) Anti-protozoan methods and materials
AU1398295A (en) Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
MX9803422A (es) Apolipoproteina e2 y tratamiento de la enfermedad de alzheimer.
HK1014498A1 (en) Bpi-protein-products for depressed reticuloendothelial system function.
AU1059095A (en) Treatment of viral disease with cd40l peptide
AU5508396A (en) Pcna binding substance
HUP9900089A3 (en) Peptide derivatives of dolastatin 15
NZ273815A (en) Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides
DE59506591D1 (de) Peptide als therapeutikum für autoimmunerkrankungen
IL116973A0 (en) Extraction of recombinant proteins
AU4012795A (en) Alzheimer's peptide
HUP9801680A3 (en) Peptides and remedy for autoimmune diseases comprising the same
EP1039931A4 (en) MULTIVALENT RECOMBINANT ANTIBODIES FOR THE TREATMENT OF HUMAN RHINOVIRUS (HRV) INFECTIONS
MC1964A1 (fr) Peptides regulateurs de l'appetit
DE69420044D1 (de) Blutregulierende peptide
EP0527774A4 (en) Calcitonin gene related peptide for the treatment of undescended testicles

Legal Events

Date Code Title Description
GB Transfer or assignment

Owner name: KOS LIFE SCIENCES, INC.

FA Abandonment or withdrawal